"Symbicort turbuhaler" - a drug that has a pronounced bronchodilator and anti-inflammatory effect. The drug is available in the form of a powder, which is intended for inhalation. An auxiliary substance used to improve the pharmacokinetic properties is lactose monohydrate.
"Symbicort turbuhaler" is used to stop attacks of bronchial asthma. Its active substances are budesonide and formoterol. They have different mechanisms of action, but exhibit a general additive effect. Thus, the frequency of asthma attacks decreases. The main route of drug penetration is inhalation. The use in small doses has an anti-inflammatory effect in the tissues of the lungs. A big plus of this drug is the low incidence of side effects. This property makes the Symbicort Turbuhaler the drug of choice for the relief of bronchial asthma attacks. The therapeutic effect occurs in a short time, the use of systemic glucocorticoids does not allow to achieve similar results, the use of drugs of this group is often accompanied by the appearance of undesirable complications. Thanks to the inclusion of formoterol in the preparation, there is a rapid relaxation of the smooth muscle cells of the bronchi, which persists for half a day after taking a dose of the drug. Chronic obstructive pulmonary disease is a disease whose symptoms also effectively stop when taking this drug.
"Symbicort turbuhaler" has a specific dosage regimen, due to the peculiarities of its pharmacokinetics and distribution dynamics in the tissues of the human body. It is intended for severe forms of bronchial asthma, which are characterized by the constant onset of seizures and resistance to other drugs. The selection of doses for each patient is carried out individually, taking into account the clinical signs of the pathological condition and tolerability of the drug. Important is the consideration of its compatibility with other medicinal substances. At emergence of hypersensitivity reactions it is necessary to cancel "Symbicort turbuhaler". The instruction for this drug includes the necessary rules of use, measures to prevent the development of fungal diseases of the oral cavity, which can develop after using the mouthpiece.
Medicinal substances can cause adverse reactions that occur infrequently and pass within a short time. The main effects include moderate tachycardia and tremor, nausea, anxiety, psychomotor agitation, depression, muscle cramps, candidiasis of the mucous membranes of the pharynx and mouth, exanthema, pruritus, urticaria, hyperglycemia. Reception in high doses can have a pronounced systemic effect. Contraindications for the use of this drug are hypersensitivity to active substances, children's age (up to six years of age is prohibited). During pregnancy, lactation, it is possible to use the drug only in case of emergency (the benefit for the mother is much higher than the risk of complications in the child). In all other situations, the Symbicort Turbuhaler is not prohibited, the feedback on the use of which in the vast majority of cases is only positive. This is due to the rapid onset of the therapeutic effect and its long-lasting effect. An undoubted advantage of this drug is the possibility of interaction with substances of other pharmacological groups. This interaction in almost all cases enhances the effect of active substances.